Speakers 2022

Speakers 2022




Accelerating Medical Innovation from Research to Patients


Andreas Wallnöfer has over 25 years of experience in the pharmaceutical and biotech industry, including 12 years as a member of the F. Hoffmann-La Roche Pharma R&D Executive Leadership team. Prior to joining Jeito Capital as Partner and Investor in 2021, he was General Partner at BioMedPartners, a Swiss based European venture capital firm. Andreas has been successful as investor and in developing innovative companies. He has been board member of several European biotech companies. Prior to his career in Venture, he has been Head of Cardiovascular & Metabolism R&D and member of the Roche / Genentech R&D Committee. Andreas was part of several successful product developments and market introductions. Before the integration of Genentech, Andreas was Global Head of Clinical Research & Exploratory Development and led the R&D organization at multiple sites in Europe, US and Asia. He had a key role in the integration of the Roche and Genentech Development organizations and led subsequently Roche’s Early Development Department. Andreas holds a PhD in Pharmacology from the University of Basel, degrees in Pharmaceutical Medicine and was trained as a Clinical Research fellow at the Centre of Human Drug Research at the University Hospital of Leiden, Netherlands. He also holds an Executive MBA from IMD Lausanne.  

Find also